Inventor · disambiguated record
Smita S. Bhat
Also filed as: BHAT SMITA · BHAT SMITA S
28 granted patents·8 pending applications·70 citations·filing 2003–2014
94Inventor score
Top patents by PatentIndex Score
36 records- 0190US7902247B2Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptorsALLERGAN INC·Filed 2008·Granted Mar 8, 2011·12 cites·15 claims
- 0282US8735438B2Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptorsSINHA SANTOSH C·Filed 2010·Granted May 27, 2014·5 cites·5 claims
- 0382US7476673B2Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptorsALLERGAN INC·Filed 2004·Granted Jan 13, 2009·20 cites·38 claims
- 0481US7226951B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2004·Granted Jun 5, 2007·13 cites·4 claims
- 0578US8227499B2Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptorsSINHA SANTOSH C·Filed 2009·Granted Jul 24, 2012·2 cites·22 claims
- 0676US8124774B2Therapeutic ((phenyl)imidazolyl)methylquinolinyl compoundsSINHA SANTOSH C·Filed 2008·Granted Feb 28, 2012·2 cites·3 claims
- 0775US8530462B2Indole modulators of S1P receptorsSINHA SANTOSH C·Filed 2011·Granted Sep 10, 2013·2 cites·14 claims
- 0874US8426454B2Therapeutic compoundsSINHA SANTOSH C·Filed 2008·Granted Apr 23, 2013·1 cites·12 claims
- 0972US8486969B2Therapeutic compoundsSINHA SANTOSH C·Filed 2008·Granted Jul 16, 2013·1 cites·11 claims
- 1071US7468391B2Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26BALLERGAN INC·Filed 2004·Granted Dec 23, 2008·5 cites·12 claims
- 1170US8993553B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsALLERGAN INC·Filed 2013·Granted Mar 31, 2015·1 cites·11 claims
- 1270US8492561B2Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulatorsSINHA SANTOSH C·Filed 2011·Granted Jul 23, 2013·1 cites·11 claims
- 1368US6683092B1[3-(c5-14alkyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-phenyl and [3-(c5-14alkyl-2-oxo-1,2,3,4- tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-heteroaryl derivatives having anti-tumor activityALLERGAN INC·Filed 2003·Granted Jan 27, 2004·4 cites·31 claims
- 1467US2010009985A1THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDSALLERGAN INC·Filed 2009·Application pending·0 cites
- 1563US8735399B2Selective subtype alpha 2 adrenergic agents and methods for use thereofHEIDELBAUGH TODD M·Filed 2009·Granted May 27, 2014·0 cites·11 claims
- 1662US8383646B2Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compoundsALLERGAN INC·Filed 2008·Granted Feb 26, 2013·0 cites·16 claims
- 1761US6936636B25-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted Aug 30, 2005·1 cites·42 claims
- 1860US8431702B2Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compoundsSINHA SANTOSH C·Filed 2012·Granted Apr 30, 2013·0 cites·8 claims
- 1959US8309729B2Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compoundsSINHA SANTOSH C·Filed 2012·Granted Nov 13, 2012·0 cites·4 claims
- 2058US8815923B2Therapeutic compoundsALLERGAN INC·Filed 2013·Granted Aug 26, 2014·0 cites·4 claims
- 2158US8188279B2Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compoundsSINHA SANTOSH C·Filed 2011·Granted May 29, 2012·0 cites·12 claims
- 2258US7432388B2Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activityALLERGAN INC·Filed 2007·Granted Oct 7, 2008·0 cites·4 claims
- 2356US7638648B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2007·Granted Dec 29, 2009·0 cites·10 claims
- 2454US8362022B2Selective subtype alpha 2 adrenergic agents and methods for use thereofALLERGAN INC·Filed 2009·Granted Jan 29, 2013·0 cites·6 claims
- 2554US7253319B2Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activityALLERGAN INC·Filed 2004·Granted Aug 7, 2007·0 cites·18 claims
- 2653US8809379B2Selective subtype alpha 2 adrenergic agents and methods for use thereofHEIDELBAUGH TODD M·Filed 2009·Granted Aug 19, 2014·0 cites·2 claims
- 2753US2014206701A1Selective subtype alpha 2 adrenergic agents and methods for use thereofALLERGAN INC·Filed 2014·Application pending·0 cites
- 2852US8541397B2Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulatorsALLERGAN INC·Filed 2013·Granted Sep 24, 2013·0 cites·8 claims
- 2952US2009281322A1THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDSALLERGAN INC·Filed 2009·Application pending·0 cites
- 3052US2014256666A1Antibiotic conjugates with nonsteroidal anti-inflammatory drugsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3151US2013338136A1Novel indole modulators of s1p receptorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 3249US8404663B2Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulatorsSINHA SANTOSH C·Filed 2011·Granted Mar 26, 2013·0 cites·8 claims
- 3349US2010273814A1((phenyl)imidazolyl)methylheteroaryl compoundsSINHA SANTOSH C·Filed 2008·Application pending·0 cites
- 3448US2012202865A1Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptorsSINHA SANTOSH C·Filed 2012·Application pending·0 cites
- 3544US2014256660A1Antibiotic conjugates linked with steroid drugsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3641US9079864B2Modulators of S1P receptorsSINHA SANTOSH C·Filed 2011·Granted Jul 14, 2015·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →